21 5

I C T

J-Doit

High risk Risk

20 7 21 34,324 30,858 38,735 26,800 27,490 20,472 18,533 20,096 14,913 14,931 488 470 491 435 446

10 t-pa intervention t-pa interventionclipping simulator subspecialty staff 2007/4/25 2007/3/23 2007/8/18 SPECT 19 2007/10/26 24 2007/3/10

32 2007/03/22 Double catheter technique 2 28 2007/08/25 66 2007/10/04 brain easy analysis tool-201thalium(beat-tl) 201Thalium 19 2007/10/26 10 primary intraosseous cavernous hemangioma 1 2007/04/14

2 1 2 URBtTURP ESWL ESWL17 ESWL TULPNL TULPNL ESWL ESWL TUL PNL 23 2007.12.9 1 3 45 26 ( 27 12 2 2 2 8 3 2008/02/16

Activated clotting time~ Al-Kayat-Bramley)

12 2 15 18 9 10 11 2 16 379 17 41318 237 10 19 566 47.240.0 267112 13244 6639 6329213 107 41 30 1 2 474 92 119.4 19 1 15 19 1987 1011 19.7 19 2 20081

(::) (:) (:) (:) (:)

19 4.25 9.12 1 5. 2 9.19 5. 9 9.26 5.16 10. 3 5.23 10.10 5.30 10.17 6. 6 10.24 6.13 6.20 11. 7 6.27 11.14 7. 4 11.21 7.25 11.28 8. 8 12. 5 8.22 12.12 8.29 12.19 9. 5 12.26 9.26 10. 3 () 10.10 () 10.17 () 10.24 () 12.12 () 12.19 () 12.26 () 1.16 () 10 1.23 () 11 3.12 (:) 12 3.26

19942003 6.0 220 960 30 4872

1112 1317 18 1516 1 14301500 4 4 14301500 17151800

(1) (2) 18 0 0 0

D E F G H I J K D E F G H I

A B C D E F G H I J A B C D E F G H I

A B C D E F G A B C D E F G DM AB 1 (1) (2) (3) (4) (1) (1) (2) (2)

A B C D E F G H A B C D E F G H I IABP CCUICU A MOFPMXCHDF HD. ICUCCU AMI BIPAP

A B C A B C 4 2 1 3

1 10 11 12 1 2 10 11 12 1 ba1c 5.8 ba1c 6.5 ()

8 10.01 4 2060 2

()

()

100

6,769 1,734 907 885 552 456 74 270 1,026 206 531 127 1 248 67 132 19 2 22 1 3 2 665 172 243 7 34 5 91 84 19 10 41 22 10 1 7 1 215 162 29 13 1 6 2 2 21 13 8 113 32 14 7 33 1 25 1 202 1 201 372 2 3 367 787 495 4 14 1 271 1 1 840 282 438 28 1 1 89 1 712 262 21 322 1 1 1 3 101 75 2 17 11 8 34 1 1 1 142 24 14 2 96 3 1 1 1 260 105 9 3 113 30 874 874 136 136 30 1 12 1 3 7 3 1 2 148 44 48 11 2 15 1 6 20 1 542 23 15 28 366 81 9 2 2 5 3 8 346 25 189 59 1 51 20 1

,.

H20221() 63 2005 15 2007 62007 7 47 10 BP150/52mmHg SpO9395(room air) 162.0cm 71.0kg () WBC 10100 /µl ALP 228 IU/l Na 139 meq/l RBC 464 /µl LDH 408 IU/l K 4.4 meq/l Hb 15.1 g/dl GTP 55 IU/l Cl 103 meq/l Plt 20.7 /µl CPK 121 IU/l Ca 9.2 meq/l PT % 64.3 % BUN 12.6 mg/dl CRP 1.4 mg/dl APTT 20.8 Cr 0.80 mg/dl TSH 0.89 µu/ml FIB 164 mg/dl UA 8.2 mg/dl FT3 2.34 pg/ml D n 23.1µg/ml T-Cho 220 mg/dl FT4 1.22 ng/ml TP 7.9 g/dl HDL-C 36 mg/dl CEA 19.5 ng/ml Alb 3.7 g/dl LDL-C 161 mg/dl CA19-9 96958 U/ml GOT 23 IU/l TG 123 mg/dl GPT 17 IU/l Glu 116 mg/dl ( ) 3 2 1 4.0 () PH 7.464 CO2 30.6 mmhg po2 50.5 mmhg HCO3 21.7 mmol/l BE 0.7 mmol/l ( XP) CTR61.8 () ( ) Af HR106 (U C G) LVH()TR71.4mmHg ( CT) () ( CT)

() VC2.61 VC68.6 FEV1.071.9 2007 7/10 7/11 PAJR PA 86/33/56 RV 83/9 RVEDP 12 RA 13/11/11 LV 151/2 Ao 147/102 ASDVSD PSAo D CT COPD MKML SpO28892 7/12 MK GIF Borrmann 4 CT CEA19.5 ng/mlca19-996958 U/ml 7/13 COPD 7/17 GIFSpO2 7/18 XPCTR65H7.464 p2 30.6p2 50.5SPO2 86.4 PPH23 SpO2 7/19 0 3

Pulmonary tumor thrombotic microangiopathypttmvon Herbay (Cancer 66587592,1990) () 0.93.3 PTTM PTTM PTTM CT VAT

19

2007Xmas's BELL 10